文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Dichotomy of protective cellular immune responses to human visceral leishmaniasis.

作者信息

Khalil E A G, Ayed N B, Musa A M, Ibrahim M E, Mukhtar M M, Zijlstra E E, Elhassan I M, Smith P G, Kieny P M, Ghalib H W, Zicker F, Modabber F, Elhassan A M

机构信息

Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

出版信息

Clin Exp Immunol. 2005 May;140(2):349-53. doi: 10.1111/j.1365-2249.2005.02768.x.


DOI:10.1111/j.1365-2249.2005.02768.x
PMID:15807861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1809358/
Abstract

Healing/protective responses in human visceral leishmaniasis (VL) are associated with stimulation/production of Th1 cytokines, such as interferon IFN-gamma, and conversion in the leishmanin skin test (LST). Such responses were studied for 90 days in 44 adult healthy volunteers from VL non-endemic areas, with no past history of VL/cutaneous leishmaniasis (CL) and LST non-reactivity following injection with one of four doses of Alum-precipitated autoclaved Leishmania major (Alum/ALM) +/- bacille Calmette-Guerin (BCG), a VL candidate vaccine. The vaccine was well tolerated with minimal localized side-effects and without an increase in antileishmanial antibodies or interleukin (IL)-5. Five volunteers (5/44; 11.4%) had significant IFN-gamma production by peripheral blood mononuclear cells (PBMCs) in response to Leishmania antigens in their prevaccination samples (P = 0.001) but were LST non-reactive. On day 45, more than half the volunteers (26/44; 59.0%) had significantly high LST indurations (mean 9.2 +/- 2.7 mm) and high IFN-gamma levels (mean 1008 +/- 395; median 1247 pg/ml). Five volunteers had significant L. donovani antigen-induced IFN-gamma production (mean 873 +/- 290; median 902; P = 0.001), but were non-reactive in LST. An additional five volunteers (5/44; 11.4%) had low IFN-gamma levels (mean 110 +/- 124 pg/ml; median 80) and were non-reactive in LST (induration = 00 mm). The remaining eight volunteers had low IFN-gamma levels, but significant LST induration (mean 10 +/- 2.9 mm; median 11). By day 90 the majority of volunteers (27/44; 61.4%) had significant LST induration (mean 10.8 +/- 9.9 mm; P < 0.001), but low levels of L. donovani antigen-induced IFN-gamma (mean 66.0 +/- 62 pg/ml; P > 0.05). Eleven volunteers (11/44; 25%) had significantly high levels of IFN-gamma and LST induration, while five volunteers had low levels of IFN-gamma (<100 pg/ml) and no LST reactivity (00 mm). One volunteer was lost to follow-up. In conclusion, it is hypothesized that cellular immune responses to human VL are dichotomatous, and that IFN-gamma production and the LST response are not in a causal relationship. Following vaccination and probably cure of VL infection, the IFN-gamma response declines with time while the LST response persists. LST is a simple test that can be used to assess candidate vaccine efficacy.

摘要

相似文献

[1]
Dichotomy of protective cellular immune responses to human visceral leishmaniasis.

Clin Exp Immunol. 2005-5

[2]
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.

Trans R Soc Trop Med Hyg. 2003

[3]
Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study.

Ann Trop Paediatr. 2006-12

[4]
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.

Clin Exp Immunol. 2003-11

[5]
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG.

Vaccine. 2001-5-14

[6]
Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

Trans R Soc Trop Med Hyg. 2008-1

[7]
Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.

Infect Immun. 2001-8

[8]
Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.

Exp Parasitol. 2012-5-10

[9]
Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.

Vaccine. 2006-4-5

[10]
Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

J Immunol. 1991-4-15

引用本文的文献

[1]
Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome.

J Epidemiol Glob Health. 2024-9

[2]
Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients.

Commun Biol. 2024-5-3

[3]
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis.

Front Immunol. 2024-2-26

[4]
A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Specific for Major Histocompatibility Complex Class I.

Int J Mol Sci. 2023-3-22

[5]
Antileishmanial Drug Discovery and Development: Time to Reset the Model?

Microorganisms. 2021-12-2

[6]
A review of the leishmanin skin test: A neglected test for a neglected disease.

PLoS Negl Trop Dis. 2021-7

[7]
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.

Clin Infect Dis. 2021-9-7

[8]
Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods.

J Parasit Dis. 2020-6

[9]
Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs.

Sci Rep. 2019-6-12

[10]
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Front Immunol. 2019-4-5

本文引用的文献

[1]
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.

Trans R Soc Trop Med Hyg. 2003

[2]
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features.

Ann Trop Med Parasitol. 2002-12

[3]
Risk mapping of visceral leishmaniasis: the role of local variation in rainfall and altitude on the presence and incidence of kala-azar in eastern Sudan.

Am J Trop Med Hyg. 2003-1

[4]
The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers.

Trans R Soc Trop Med Hyg. 2002

[5]
Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.

Clin Diagn Lab Immunol. 2002-9

[6]
Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.

Trop Med Int Health. 2002-1

[7]
IL-10 mediates susceptibility to Leishmania donovani infection.

Eur J Immunol. 2001-10

[8]
Leishmaniasis in Sudan. Visceral leishmaniasis.

Trans R Soc Trop Med Hyg. 2001-4

[9]
Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.

Vaccine. 2001-2-28

[10]
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

Lancet. 2000-11-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索